Page last updated: 2024-10-24

carprofen and Cirrhosis, Liver

carprofen has been researched along with Cirrhosis, Liver in 1 studies

carprofen: RN given refers to cpd without isomeric designation
carprofen : Propanoic acid in which one of the methylene hydrogens is substituted by a 6-chloro-9H-carbazol-2-yl group. A non-steroidal anti-inflammatory drug, it is no longer used in human medicine but is still used for treatment of arthritis in elderly dogs.

Research Excerpts

ExcerptRelevanceReference
" The pharmacokinetic parameters and urinary excretion data did not differ significantly (P greater than 0."2.66The influence of liver dysfunction on the pharmacokinetics of carprofen. ( Brazzell, RK; Chen, SS; Holazo, AA; Konikoff, JJ; McMahon, FG; Ryan, JR, 1985)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Holazo, AA1
Chen, SS1
McMahon, FG1
Ryan, JR1
Konikoff, JJ1
Brazzell, RK1

Trials

1 trial available for carprofen and Cirrhosis, Liver

ArticleYear
The influence of liver dysfunction on the pharmacokinetics of carprofen.
    Journal of clinical pharmacology, 1985, Volume: 25, Issue:2

    Topics: Adult; Anti-Inflammatory Agents; Carbazoles; Clinical Trials as Topic; Female; Half-Life; Hepatitis;

1985